0001785673-19-000002.txt : 20190926 0001785673-19-000002.hdr.sgml : 20190926 20190926120847 ACCESSION NUMBER: 0001785673-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190926 DATE AS OF CHANGE: 20190926 EFFECTIVENESS DATE: 20190926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elion Oncology, Inc. CENTRAL INDEX KEY: 0001785673 IRS NUMBER: 812434558 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-349693 FILM NUMBER: 191116652 BUSINESS ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 301-651-4256 MAIL ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: Elion Oncology, LLC DATE OF NAME CHANGE: 20190816 D 1 primary_doc.xml X0708 D LIVE 0001785673 Elion Oncology, Inc. 4800 HAMPDEN LANE SUITE 200 BETHESDA MD MARYLAND 20814 301-651-4256 MARYLAND Elion Oncology, LLC Corporation true 2016 R. MICHAEL FLOYD 4800 HAMPDEN LANE SUITE 200 BETHESDA MD MARYLAND 20814 Executive Officer Director Promoter LORENZO LEONI 4800 HAMPDEN LANE SUITE 200 BETHESDA MD MARYLAND 20814 Executive Officer Director JAMIE OLIVER 4800 HAMPDEN LANE SUITE 200 BETHESDA MD MARYLAND 20814 Director Pharmaceuticals Decline to Disclose 06b false 2019-09-26 false true true true Convertible promissory note that converts into capital stock in certain circumstances false 0 Indefinite 1000000 Indefinite false 1 0 0 0 false Elion Oncology, Inc. R. Michael Floyd R. Michael Floyd President and CEO 2019-09-26